A new mobile app can help clinicians easily identify, grade and manage immuno-oncology (IO) toxicities using guidelines from the American Society of Clinical Oncology (ASCO) and the National Cancer Institute (NCI).
The app fills an important need, according to app co-developer University of Texas MD Anderson Cancer Center. “Managing these side effects is essential to the success of immune checkpoint inhibitors and a patient’s recovery,” the cancer center noted, adding